Outcome measures in rheumatoid arthritis: the OMERACT process.
Peter Brooks, Maarten Boers, Lee S Simon, Vibeke Strand, Peter Tugwell
Expert Rev Clin Immunol | Published : 2007
The development of valid outcome measures is essential for appropriate management of any condition, but particularly chronic rheumatic diseases, such as rheumatoid arthritis. Over the last 15 years, Outcome Measures in Arthritis Clinical Trials has been dedicated to developing such measures in a variety of musculoskeletal conditions, including rheumatoid arthritis, osteoarthritis, osteoporosis, ankylosing spondylitis and gout.